Design Therapeutics, Inc. (DSGN) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
DSGN Revenue Growth
DSGN Revenue Analysis (2019–2025)
As of May 8, 2026, Design Therapeutics, Inc. (DSGN) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue.
Looking at the longer-term picture, DSGN's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $834 in 2019.
When compared to Healthcare sector peers including EXAS (+17.7% YoY), ARQT (+95.3% YoY), and BEAM (+108.0% YoY). Compare DSGN vs EXAS →
DSGN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| DSGNCurrent | $0 | - | - | - | |
 EXAS | $3.2B | +17.7% | +16.8% | -6.4% | |
 ARQT | $376M | +95.3% | - | -3.3% | |
 BEAM | $140M | +108.0% | +466.3% | -274.6% |
DSGN Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-622,000 | - | $-79,467,000 | - |
| 2024 | $0 | - | $-596,000 | - | $-62,383,000 | - |
| 2023 | $0 | - | $-537,000 | - | $-78,190,000 | - |
| 2022 | $0 | - | $-466,000 | - | $-67,593,000 | - |
| 2021 | $0 | - | $0 | - | $-35,831,000 | - |
| 2020 | $0 | -100.0% | $-5,000 | - | $-8,556,000 | - |
| 2019 | $834 | - | $-820 | -98.3% | $-1,908,000 | -228777.0% |
See DSGN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DSGN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DSGN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonDSGN — Frequently Asked Questions
Quick answers to the most common questions about buying DSGN stock.
Is DSGN's revenue growth accelerating or slowing?
DSGN TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is DSGN's long-term revenue growth rate?
Design Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is DSGN's revenue distributed by segment?
DSGN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.